Phreesia, Inc. (0A23.L)
USD 28.5
(-1.96%)
USD 28.5
(-1.96%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -75.53 Million USD | 54.9% |
| 2023 | -167.5 Million USD | 43.79% |
| 2022 | -298.01 Million USD | -45.76% |
| 2021 | -204.46 Million USD | -207.69% |
| 2020 | -66.45 Million USD | -316.15% |
| 2019 | 30.74 Million USD | 147.3% |
| 2018 | 12.43 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -75.53 Million USD | 15.15% |
| 2024 FY | -75.53 Million USD | 54.9% |
| 2024 Q1 | -135.14 Million USD | 19.32% |
| 2024 Q2 | -111.87 Million USD | 17.22% |
| 2024 Q3 | -89.02 Million USD | 20.43% |
| 2023 Q1 | -254.84 Million USD | 14.49% |
| 2023 Q4 | -167.5 Million USD | 15.72% |
| 2023 FY | -167.5 Million USD | 43.79% |
| 2023 Q3 | -198.73 Million USD | 12.89% |
| 2023 Q2 | -228.14 Million USD | 10.47% |
| 2022 Q2 | -427.21 Million USD | 2.5% |
| 2022 Q4 | -298.01 Million USD | 23.28% |
| 2022 Q3 | -388.43 Million USD | 9.08% |
| 2022 Q1 | -438.19 Million USD | -114.32% |
| 2022 FY | -298.01 Million USD | -45.76% |
| 2021 FY | -204.46 Million USD | -207.69% |
| 2021 Q1 | -63.19 Million USD | 4.91% |
| 2021 Q2 | -53.51 Million USD | 15.31% |
| 2021 Q3 | -221.51 Million USD | -313.93% |
| 2021 Q4 | -204.46 Million USD | 7.7% |
| 2020 Q1 | 32.06 Million USD | 4.3% |
| 2020 FY | -66.45 Million USD | -316.15% |
| 2020 Q2 | -76.22 Million USD | -337.72% |
| 2020 Q4 | -66.45 Million USD | 1.77% |
| 2020 Q3 | -67.65 Million USD | 11.25% |
| 2019 Q1 | 10.5 Million USD | 0.0% |
| 2019 Q4 | 30.74 Million USD | 0.0% |
| 2019 FY | 30.74 Million USD | 147.3% |
| 2018 FY | 12.43 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accuray Incorporated | 103.58 Million USD | 172.922% |
| Align Technology, Inc. | -840.47 Million USD | 91.013% |
| Elevance Health Inc. | 18.59 Billion USD | 100.406% |
| AxoGen, Inc. | 32.26 Million USD | 334.107% |
| Boston Scientific Corporation | 8.23 Billion USD | 100.918% |
| CVS Health Corporation | 71.18 Billion USD | 100.106% |
| Cardinal Health, Inc. | 476 Million USD | 115.869% |
| Centene Corporation | 506 Million USD | 114.928% |
| DaVita Inc. | 10.65 Billion USD | 100.709% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 100.185% |
| Hologic, Inc. | 374.4 Million USD | 120.175% |
| Humana Inc. | 5.51 Billion USD | 101.369% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 115.293% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 101.394% |
| Masimo Corporation | 804 Million USD | 109.395% |
| McKesson Corporation | 889 Million USD | 108.497% |
| Patterson Companies, Inc. | 648.47 Million USD | 111.648% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 101.613% |
| ResMed Inc. | 635.57 Million USD | 111.885% |
| Henry Schein, Inc. | 2.57 Billion USD | 102.939% |
| Teladoc Health, Inc. | 468.6 Million USD | 116.12% |
| Universal Health Services, Inc. | 5.24 Billion USD | 101.44% |
| Veeva Systems Inc. | -647.71 Million USD | 88.338% |
| Baxter International Inc. | 11.16 Billion USD | 100.676% |
| Becton, Dickinson and Company | 14.46 Billion USD | 100.522% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 97.161% |
| Danaher Corporation | 13.49 Billion USD | 100.56% |
| Stryker Corporation | 10.02 Billion USD | 100.754% |
| Medtronic plc | 23.67 Billion USD | 100.319% |